Your Autoimmune Risk Is Written in Your HLA Type. Here's What It Means.

Your HLA (human leukocyte antigen) genes are the ID badges of your immune system. They sit on the surface of your cells and display protein fragments to your T-cells, essentially saying, “Is this one of ours or a foreign invader?” HLA-DQ2 is one of the most important of these ID systems. It determines which specific proteins your immune system will recognize as foreign and mount an attack against.

Approximately 25-30% of people of European ancestry carry the HLA-DQ2 variant. If you carry it, your immune system is genetically wired to recognize certain proteins as threats that other people’s immune systems would ignore. This single gene variant is present in nearly all celiac disease cases and dramatically increases risk for type 1 diabetes, other autoimmune diseases, and inflammatory conditions. It’s not that HLA-DQ2 is defective; it’s that it’s hypervigilant.

If you have HLA-DQ2, your immune system will treat certain protein patterns as immediate threats, triggering T-cell activation and inflammatory cascades. Over time, this can lead to tissue damage in your gut (celiac disease), pancreas (type 1 diabetes), joints (rheumatoid arthritis), or other tissues depending on what other genes and environmental triggers you have. You might notice this as chronic inflammation, joint pain, digestive issues, or fatigue that flares with certain foods or stressors.

Your T-cells are the special operations team of your immune system. They need to activate quickly to fight infections, but they also need a strong off switch, or they’ll keep attacking long after the threat is gone. CTLA4 is that off switch. It sits on T-cells and sends the signal: “Stop. You’re done now.” When CTLA4 is working properly, your T-cells activate, do their job, then turn off. When it’s not, they stay active and keep attacking.

The CTLA4 +49A>G variant is carried by approximately 45% of the population. People with the G allele have reduced CTLA4 function, meaning their T-cells are slower to receive the “stand down” signal. This doesn’t mean you’ll definitely develop autoimmune disease, but it means your T-cells are biased toward staying activated longer than they should.

You might experience this as a tendency toward chronic inflammation, frequent infections (because your T-cells stay too active and exhaust themselves), or early signs of autoimmune disease like joint stiffness, recurrent infections, or systemic inflammation. Your body is essentially stuck in a higher baseline state of immune activation, even when there’s no active threat.

TNF is tumor necrosis factor-alpha, one of the most potent inflammatory molecules your body produces. It’s your immune system’s megaphone. When you have an infection or injury, TNF amplifies the inflammatory signal so your immune system mobilizes quickly. But if you’re producing too much TNF, your whole system becomes hyperinflammatory. Everything feels like a bigger threat than it is.

The TNF -308G>A variant is carried by approximately 30% of people with European ancestry. People with the A allele produce significantly more TNF-alpha than those with the GG genotype. This higher TNF production drives systemic inflammation and substantially increases autoimmune disease risk, particularly rheumatoid arthritis, lupus, and Crohn’s disease. Your immune system is essentially running at a higher baseline inflammatory volume.

You might feel this as constant joint inflammation, chronic pain, recurrent infections, or a general sense of your body being “activated.” Foods that trigger inflammation hit you harder. Stress impacts you more severely. Your body struggles to downregulate inflammation even after the initial threat is gone. You might notice you’re more sensitive to NSAIDs, need more sleep to recover, or have unexplained fatigue alongside inflammatory markers that are borderline elevated.

IL-6 is interleukin-6, the cytokine that amplifies inflammatory signals throughout your entire body. When TNF turns up the volume, IL-6 makes sure everyone hears it. It’s the difference between a localized inflammation and systemic inflammation. IL-6 activates your brain’s inflammatory response too, which is why people with high IL-6 often experience brain fog, depression, or fatigue alongside physical inflammation.

The IL6 -174G>C variant is carried by approximately 40% of the population. People with the C allele produce more IL-6, which means their inflammatory signals spread wider and persist longer. Higher IL-6 production amplifies the overall inflammatory response and drives neuroinflammation, making it a major contributor to both autoimmune disease and mood disorders. You’re essentially wired for a more systemic, sustained inflammatory state.

You might experience this as brain fog that correlates with physical inflammation, depression or anxiety that flares with inflammatory triggers, widespread joint pain, or fatigue that seems disproportionate to your activity level. When you do get sick or injured, your recovery is slower because the inflammatory signal is louder and takes longer to quiet down. Cognitive symptoms improve when systemic inflammation improves.

PTPN22 is a phosphatase that acts like a precision dial on your immune system. It fine-tunes T-cell signaling to help your immune system distinguish between your own cells and foreign invaders. When PTPN22 is working properly, this distinction is clear. When it’s not, your T-cells become confused and start attacking your own tissues. It’s the difference between a well-trained guard who knows exactly who to let through and a jumpy guard who suspects everyone.

The PTPN22 1858C>T variant is carried by approximately 5-15% of people of European ancestry, but in those who carry it, the autoimmune risk is substantial. People with the T allele have altered PTPN22 function, which impairs their immune system’s ability to distinguish self from non-self. This single gene variant is associated with multiple autoimmune conditions including rheumatoid arthritis, lupus, type 1 diabetes, and Graves’ disease.

If you carry the PTPN22 variant, your immune system is biased toward treating your own tissues as threats. You might develop one autoimmune disease or multiple. You might notice autoimmune symptoms earlier in life than your parents or siblings without this variant. Over time, repeated immune attacks on the same tissue lead to cumulative damage. This variant often runs in families with multiple autoimmune conditions.

IRF5 is interferon regulatory factor 5, a transcription factor that controls whether your cells activate pro-inflammatory genes in response to viral or bacterial threats. When you encounter a pathogen, IRF5 helps decide which genes to turn on. In people with IRF5 variants, this response is overactive. Your cells are too quick to activate the full inflammatory arsenal even for minor threats.

The IRF5 variants associated with autoimmune disease are complex, but the functional outcome is clear: people carrying certain IRF5 variants have substantially elevated risk for lupus, rheumatoid arthritis, and other systemic autoimmune conditions. Approximately 20-30% of people carry autoimmune-associated IRF5 variants. Your cells are primed to interpret threats as more severe than they actually are.

You might experience this as an exaggerated inflammatory response to infections, longer recovery times from illness, or unexplained systemic symptoms like fever, joint pain, or fatigue that seem disproportionate to the trigger. If you’re managing an autoimmune condition, IRF5 variants often correlate with more severe disease. You might notice your symptoms flare more dramatically with stress or immune challenges.